An official website of the United States government
Here's how you know
Official websites use .mil
A
.mil
website belongs to an official U.S. Department of Defense organization in the United States.
Secure .mil websites use HTTPS
A
lock (
lock
)
or
https://
means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.
Skip to main content (Press Enter).
HOME
LEADERSHIP
Commander
Deputy Commander
Chief of Staff
Senior Enlisted Leader
Leadership
ABOUT USINDOPACOM
History
USINDOPACOM Area of Responsibility
USPACOM Previous Commanders
Organization Chart
Women, Peace and Security
Indo-Pacific Health Security Alliance - IPhsa
Counter-Lawfare: Tactical Aids & Legal Vigilance Products
About USINDOPACOM
MEDIA
NEWS
Press Releases and Readouts
Photos
Speeches / Testimony
Freedom of Information Act
FOIA - Reading Room
Submit FOIA Request
Request Status
FOIA FAQS
2024 Banner Photos
Media
RESOURCES
Travel Requirements
Useful Theater Information
ATFP FAQs
Useful Links
Newcomers
Resources
CONTACT
Directory
Media Inquiries
Industry Engagements
Contact
JTF - RED HILL
JTF-MICRONESIA
Search
Home
Media
NEWS
News Article View
Home
Media
NEWS
News Article View
HOME
LEADERSHIP
Commander
Deputy Commander
Chief of Staff
Senior Enlisted Leader
ABOUT USINDOPACOM
History
USINDOPACOM Area of Responsibility
USPACOM Previous Commanders
Organization Chart
Women, Peace and Security
Indo-Pacific Health Security Alliance - IPhsa
Counter-Lawfare: Tactical Aids & Legal Vigilance Products
MEDIA
NEWS
Press Releases and Readouts
Photos
Speeches / Testimony
Freedom of Information Act
FOIA - Reading Room
Submit FOIA Request
Request Status
FOIA FAQS
2024 Banner Photos
RESOURCES
Travel Requirements
Useful Theater Information
ATFP FAQs
Useful Links
Newcomers
CONTACT
Directory
Media Inquiries
Industry Engagements
JTF - RED HILL
JTF-MICRONESIA
U.S. Government Provides Fast COVID-19 Testing Machines and Biosafety Equipment to Tuberculosis Hospital in Bangladesh
27 July 2020
Download
DHAKA, Bangladesh -- Ambassador Earl R. Miller visited the 250-bed Tuberculosis (TB) Hospital in Shyamoli, Dhaka to observe how U.S. government-provided GeneXpert machines can detect COVID-19 within 45 minutes and handed over equipment to improve diagnosis of multi-drug resistant TB (MDR-TB) on July 27, 2020.
The U.S. government, through the United States Agency for International Development (USAID), has provided more than $100 million over the last ten years to support the National TB Control Program to reduce the TB burden in Bangladesh. Since March 2020, The United States Embassy has also extended financial and technical support to complement the Government of Bangladesh’s COVID-19 readiness and response efforts.
During the visit, Ambassador Miller observed how the NTP uses the GeneXpert machines to complete COVID-19 tests at the hospital within 45 minutes, allowing physicians to begin treatment for COVID-19 positive patients without delay. USAID previously provided 74 GeneXpert machines to the Government of Bangladesh for TB testing, which are now also being used to test for COVID-19. The GeneXpert system is produced by Cepheid, a California-based company, and is capable of on demand tests for a range of diseases, including TB and COVID-19. Ambassador Miller met medical technologists at the hospital laboratory who received U.S.-supported training to develop their skills to effectively use the GeneXpert machines for COVID-19 testing.
Although the COVID-19 pandemic has recently demanded the world’s attention, TB remains the leading cause of death by a single infectious disease globally and a top cause of death in Bangladesh. To improve the diagnosis of MDR-TB Ambassador Miller also handed over two mycobacteria growth indicator tube (MGIT) machines to NTP.
The U.S. government was one of the first donors to mobilize funds to support Bangladesh’s COVID-19 readiness and response efforts, contributing over $56.5 million from all agencies so far, including nearly $37 million from USAID for development and humanitarian assistance. This assistance strengthens the COVID-19 testing capacity of Bangladesh’s laboratories and laboratory staff; improves the care of COVID-19 patients; reduces and controls the spread of the infection; increases public knowledge; and dispels myths and misconceptions about the disease.
The U.S. government, through USAID, has provided more than $7 billion in development assistance to Bangladesh since 1971, including more than $1 billion in health-related support. In 2019, USAID provided over $200 million to improve the lives of people in Bangladesh through programs that expand food security and economic opportunity, improve health and education, promote democratic institutions and practices, protect the environment, and increase resilience to climate change.
Guidance-Card-Icon
Dept-Exclusive-Card-Icon